Johnson & Johnson Hit With $8 Billion Jury Verdict in Risperdal Suit

A Philadelphia jury found that a subsidiary downplayed the risks that the anti-psychotic drug could lead to breast growth in boys.
By BY MIHIR ZAVERI AND KATIE THOMAS from NYT Health https://ift.tt/31YDhZP
via IFTTT
your-feed-science, Drugs (Pharmaceuticals), Suits and Litigation (Civil), Fines (Penalties)
Source New York Times
Làm đẹp Blog 247